Back
NuCana PLC Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Sell
42
NCNA
NuCana PLC
Last Price:
2.65
Seasonality Move:
-12.75%
Sell
42
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
0.90
Seasonality Move:
-1.3%
Sell
42
NuCana PLC (NCNA)
is a Sell
Is NuCana PLC a Buy, Sell or Hold?
- The current NuCana PLC [NCNA] share price is $2.77. The Score for NCNA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NCNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $0.89. The Score for BDRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NCNA Stock Price Chart
What is NuCana PLC's stock price today?
-
The NuCana PLC share price today is $2.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $0.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing slight buying pressure.
NCNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 34.51 | Sell |
Chaikin Money Flow: | 5001 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.81 - 3.45) | Sell |
Bollinger Bands (100): | (3.18 - 7.68) | Sell |
BDRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 44.61 | Sell |
Chaikin Money Flow: | 42635 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.91 - 1.03) | Sell |
Bollinger Bands (100): | (0.88 - 1.4) | Sell |
NCNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.8 | Sell |
20-day SMA: | 3.02 | Sell |
50-day SMA: | 3.46 | Sell |
200-day SMA: | 8.19 | Sell |
8-day EMA: | 2.79 | Sell |
20-day EMA: | 3.01 | Sell |
50-day EMA: | 3.74 | Sell |
200-day EMA: | 8.6 | Sell |
BDRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.92 | Sell |
20-day SMA: | 0.96 | Sell |
50-day SMA: | 1.05 | Sell |
200-day SMA: | 2.22 | Sell |
8-day EMA: | 0.91 | Sell |
20-day EMA: | 0.96 | Sell |
50-day EMA: | 1.05 | Sell |
200-day EMA: | 28.3 | Sell |
NuCana PLC Earnings Growth & NCNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.09 per share, an increase this year of $2.64 per share, and a decrease next year of $3.67 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
NuCana PLC Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biodexa Pharmaceuticals Plc Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |